Global Post-Authorization Safety Surveillance Study: real-world data on prophylaxis and on-demand treatment using FEIBA (an activated prothrombin complex concentrate)

This prospective, Post-Authorization Safety Surveillance (PASS) study was carried out in patients with hemophilia A or B and inhibitors treated with FEIBA for 1 year to collect real-world data on safety and effectiveness of FEIBA. The study followed a cohort design and did not make stipulations on t...

Descripción completa

Detalles Bibliográficos
Autores principales: Negrier, Claude, Voisin, Sophie, Baghaei, Fariba, Numerof, Robert, Novack, Aaron, Doralt, Jennifer E., Romanov, Vadim, Gringeri, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams And Wilkins 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935538/
https://www.ncbi.nlm.nih.gov/pubmed/26829366
http://dx.doi.org/10.1097/MBC.0000000000000525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935538/
https://www.ncbi.nlm.nih.gov/pubmed/26829366
http://dx.doi.org/10.1097/MBC.0000000000000525

Ejemplares similares